Overview

Extended Release Naltrexone for Opioid-Dependent Youth

Status:
Completed

Trial end date:
2019-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare 6-month treatment outcomes for 15-21 year old opioid-dependent youth receiving extended release naltrexone (XR-NTX) v. Treatment as Usual (TAU).

Phase:

Phase 4

Details

Lead Sponsor:

Friends Research Institute, Inc.

Collaborator:

National Institute on Drug Abuse (NIDA)

Treatments:

Analgesics, Opioid
Buprenorphine
Naltrexone